Cancer

PRECEDE Consortium Marks Milestone in Pancreatic Cancer Battle with 5th Annual Meeting

Global experts gather at Cornell Tech, advancing early detection and survival in pancreatic cancer fightNEW YORK, NY / ACCESSWIRE /…

12 months ago

Quest International and CLS America Forge Partnership to Accelerate Commercialization Efforts for the TRANBERG Laser Ablation System in US Market

IRVINE, CA / ACCESSWIRE / December 8, 2023 / Quest International, a global aftermarket service support partner for Healthcare and…

12 months ago

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Adoption of the technology at UTMB Health Clear Lake Campus Hospital follows successful evaluation process in these procedures—reporting 100% success…

12 months ago

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

12 months ago

Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers

CHICAGO, IL / ACCESSWIRE / December 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

12 months ago

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

122 Patients Enrolled in Single-arm IDE Study; 30-Day Follow-upLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology…

12 months ago

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

122 Patients Enrolled in Single-arm IDE Study; 30-Day Follow-upLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology…

12 months ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the…

12 months ago

First Patient Dosed in Spago Nanomedical’s Clinical Phase I/IIa Study within the Tumorad(R) Program

LUND, SE / ACCESSWIRE / December 07, 2023 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the…

12 months ago